Acupuncture for chronic stable angina pectoris at acupoints on the involved meridian: a multi-center, randomized, controlled trial
- Conditions
- chronic stable angina pectoris
- Registration Number
- ITMCTR1900002585
- Lead Sponsor
- Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Matching the diagnostic criteria of CSAP according to the Chinese Society of Cardiology;
2. Meeting Class I or II of the Canadian Cardiovascular Society (CCS) angina pectoris severity grade;
3. Aging from 45 to 70 years;
4. Having experienced angina attack in at least the last three months, and the attack frequency >= twice a week in the most recent month;
5. At least 2 months of standardized medication history before enrolment (sustaining the same medication, usage, and dose). Basic therapeutic drug is one or more of the following: ß-blockers, angiotensin converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers(ARB), antiplatelet medications and statins;
6. Having signed informed consent.
1. Being pregnant or during lactation or intending to be pregnant in the 6 months;
2. Having severe cardiovascular, digestive, urinary, respiratory, hematological, nervous, or endocrine system diseases that cannot be controlled with clinical treat-ments;
3. Converting to acute coronary syndrome (including acute myocardial infarction and unstable angina pectoris), serious arrhythmia (advanced atrioventricular block, ventricular tachycardia, supraventricular tachycardia, frequent premature beats);
4. Being accompanied with serious psychiatric illness;
5. Failing to control hypertension (systolic blood pressure >= 140 mm Hg and/or diastolic blood pressure >= 90 mm Hg) or diabetes mellitus (HbA1 above 7% in last three months);
6. Having received acupuncture therapy due to cardiovascular illness in the last 1 month;
7. Having bleeding tendency and dermatitis;
8. Being in allergic constitution and be allergic to adhesive tape;
9. Participating in any other clinical trials.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method